GYRE THERAPEUTICS, INC. (GYRE) › Total AssetsGYRE THERAPEUTICS, INC. (GYRE) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $262.79M2011: $258.13M2012: $189.58M2013: $145.87M2014: $2.98M2015: $69.52M2016: $38.09M2017: $39.51M2018: $124.92M2019: $98.55M2020: $94.85M2021: $55.66M2022: $84.75M2023: $116.54M2024: $125.41M2025: $166.13M$166.13M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$166.13M+32.5%2024$125.41M+7.6%2023$116.54M+37.5%2022$84.75M+52.3%2021$55.66M-41.3%2020$94.85M-3.8%2019$98.55M-21.1%2018$124.92M+216.1%2017$39.51M+3.7%2016$38.09M-45.2%2015$69.52M+2232.1%2014$2.98M-98.0%2013$145.87M-23.1%2012$189.58M-26.6%2011$258.13M-1.8%2010$262.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share